{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:33:34Z","timestamp":1769024014572,"version":"3.49.0"},"reference-count":23,"publisher":"Index Copernicus","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2020,2,5]]},"abstract":"<jats:p>Background: Though the absence of vertigo in Meniere disease is often interpreted as remission, patient-centered subjective assessment of quality of life remains the best indicator of such remission. Study Objective: To assess the presence and severity of aural pressure\/tinnitus, hearing loss, unsteadiness, nausea and vomiting in MD patients during remission. Setting: Urban tertiary care referral hospital in a developing country. Methodology: Consecutive patients with diagnosis of Definite Meniere were selected from the Balance and Dizziness Clinic of National Hospital Abuja for the study. Quality of life assessment was carried out using 3 validated tools \u2013 Modified MD-POSI, Vertigo Symptom Scale and Tinnitus Handicap Inventory (THI). Patients were included only when they have been vertigo free for at least 4 weeks. Pure tone audiometry was carried out in those with subjective hearing loss at recruitment and 4 weeks later. Results: A total of 26 patients completed the study. All had cinnarizine for acute vertigo control and Betahistine for maintenance of vertigo control. There was female preponderance (17:9). The age range was 32\u201356 years. The duration of MD ranges from 4 months to 12 years. The total and subscale MD-POSI scores for \u201cbetween attacks\u201d significantly correlated with hearing, unsteadiness and tinnitus\/pressure when compared to during attack. 69.2 per cent of participants experienced symptoms of unsteadiness during remission. 13\/26 of participants reported persistent, though less annoying tinnitus that poorly correlated with THI score during remission. Conclusion: Our study showed that significant non-vertigo symptoms affect the quality of life during remission. Perhaps there is need to properly define, in future studies, what constitutes remission in patients with MD.\n\n<\/jats:p>","DOI":"10.5604\/01.3001.0013.7927","type":"journal-article","created":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T08:49:27Z","timestamp":1585126167000},"page":"31-36","source":"Crossref","is-referenced-by-count":4,"title":["Persistence of Non-Vertigo Symptoms in Meniere Disease During Remission \u2013 A Preliminary Report"],"prefix":"10.5604","volume":"74","author":[{"given":"Abiodun","family":"Olusesi","sequence":"first","affiliation":[{"name":"Department of Ear, Nose & Throat, National Hospital Abuja, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olubukola","family":"Oyeniran","sequence":"additional","affiliation":[{"name":"Ent Department, General Hospital, Orile-agege, Lagos, Nigeria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"197395r1","unstructured":"Crowson M.G., Schulz K., Parham K., Vambutas A., Witsell D. et al.: Menieres\u2019sdisease \u2013 A \u2018CHEER\u2019 Database of Local and Regional Patient Encounterand Procedure Patterns. Otolaryngol Head Neck Surg., 2016; 155(1): 15\u201321."},{"key":"197395r2","doi-asserted-by":"crossref","unstructured":"Adrion C., Fischer C.S., Wagner J., G\u00fbrkov R., Mansmann U. et al.: Efficacyand safety in patients with Meniere\u2019s disease: primary results of a long termmulti center, double blind, randomized, placebo controlled, dose defining trial(BEMED). BMJ, 2016; 352: h6816.","DOI":"10.1136\/bmj.h6816"},{"key":"197395r3","doi-asserted-by":"crossref","unstructured":"Olusesi A.D., Abubakar J.: 10 years of Vertigo Clinic at National Hospital Abuja,Nigeria: what have we learned? Eur Arch Otorhinolaryngol., 2016; 273(11):3567\u20133572. Epub 2016 Mar 9.","DOI":"10.1007\/s00405-016-3969-6"},{"key":"197395r4","doi-asserted-by":"crossref","unstructured":"Olusesi A.D., Hassan S.B., Oyeyipo Y., Ukwuije U.C., Oyeniran O.: Chemicallabyrinthectomy for the worse ear of adult Nigerians with bilateral Meniere\u2019sdisease: preliminary report of treatment outcomes. Eur Arch Otorhinolaryngol.,2015; 272(6): 1383\u20131387. DOI: 10.1007\/s00405-014-2947-0. Epub 2014 Feb 26.","DOI":"10.1007\/s00405-014-2947-0"},{"key":"197395r5","doi-asserted-by":"crossref","unstructured":"Nakagawa H., Watanabe Y., Larsen H.Ch.: Matti Anniko Subjective Visual Verticaland Vertigo. Equilibrium Research, 1998; 57(1): 69\u201374.","DOI":"10.3757\/jser.57.69"},{"key":"197395r6","doi-asserted-by":"crossref","unstructured":"Masuyama K., Uno K., Minoda R., Eura M., Samejima Y. et al.: MuscarinicAcetylcholine Receptors on Human Lymphocytes in Patients with Meniere\u2019sDisease. Acta Oto-Laryngologica, 1996; 116(3): 369\u2013373.","DOI":"10.3109\/00016489609137859"},{"key":"197395r7","doi-asserted-by":"crossref","unstructured":"Kitahara T., Horii A., Kondoh K., Okumura S., Kubo T.: [Dynamic vestibularcompensation in vestibular peripheral diseases]. Nippon Jibiinkoka GakkaiKaiho, 2007; 110(11): 720\u2013727.","DOI":"10.3950\/jibiinkoka.110.720"},{"key":"197395r8","unstructured":"Kakigi A., Takeda T.: Antidiuretic hormone and osmolality in patients withM\u00e9ni\u00e8re\u2019s disease. ORL J. Otorhinolaryngol. Relat. Spec., 2009; 71(1): 11\u201313."},{"key":"197395r9","unstructured":"Murphy M.P., Gates G.A.: Measuring the effects of Meniere\u2019s disease: resultsof the Patient-Oriented Severity Index (MD POSI) version 1. Ann Otol RhinolLaryngol., 1999; 108(4): 331\u2013337."},{"key":"197395r10","unstructured":"Gates G.A., Verrall A.M.: Validation of the M\u00e9ni\u00e8re\u2019s Disease Patient-OrientedSymptom-Severity Index. Arch Otolaryngol Head Neck Surg., 2005; 131(10):863\u2013867."},{"key":"197395r11","doi-asserted-by":"crossref","unstructured":"Kondo M., Kiyomizu K., Goto F., Kitahara T., Imai T. et al.: Analysis of vestibular-balance symptoms according to symptom duration: dimensionality ofthe Vertigo Symptom Scale-short form. Health Qual Life Outcomes., 2015;13: 4. DOI: 10.1186\/s12955-015-0207-7.","DOI":"10.1186\/s12955-015-0207-7"},{"key":"197395r12","doi-asserted-by":"crossref","unstructured":"Bisdorff A., Brevern M.V., Lempert T., Newman-Toker D.E.: Classificationof vestibular symptoms: Towards an international classification of vestibulardisorders First consensus document of the Committee for the Classificationof Vestibular Disorders of the Barany Society. Journal of Vestibular Research,2019; 19: 1\u201313. DOI:10.3233\/VES-2009-0343.","DOI":"10.3233\/VES-2009-0343"},{"key":"197395r13","doi-asserted-by":"crossref","unstructured":"Levo H., Stephens D., Poe D., Kentala E., Rasku J. et al.: EuroQol 5D quality oflife in Meni\u00e8re\u2019s disorder can be explained with symptoms and disabilities. IntJ Rehabil Res., 2012; 35(3): 197\u2013202. DOI: 10.1097\/MRR.0b013e3283531f95.","DOI":"10.1097\/MRR.0b013e3283531f95"},{"key":"197395r14","unstructured":"Boleas-Aguirre M.S., S\u00e1nchez-Ferrandiz N., Guill\u00e9n-Grima F., Perez N.: Long--term disability of class A patients with M\u00e9ni\u00e8re\u2019s disease after treatment withintratympanic gentamicin. Laryngoscope., 2007; 117(8): 1474\u20131481."},{"key":"197395r15","doi-asserted-by":"crossref","unstructured":"Gottshall K.R., Topp S.G., Hoffer M.E.: Early vestibular physical therapy rehabilitationfor Meniere\u2019s disease. Otolaryngol Clin North Am., 2010; 43(5):1113\u20131119. DOI: 10.1016\/j.otc.2010.05.006.","DOI":"10.1016\/j.otc.2010.05.006"},{"key":"197395r16","doi-asserted-by":"crossref","unstructured":"Stephens D., Pyykk\u00f6 I., Yoshida T., Kentala E., Levo H. et al.: The consequencesof tinnitus in long-standing M\u00e9ni\u00e8re\u2019s disease. Auris Nasus Larynx., 2012;39(5): 469\u2013474. DOI: 10.1016\/j.anl.2011.10.011. Epub 2011 Nov 16.","DOI":"10.1016\/j.anl.2011.10.011"},{"key":"197395r17","doi-asserted-by":"crossref","unstructured":"Quatre R., Atty\u00e9 A., Karkas A., Job A., Dumas G. et al.: Relationship betweenangio-vestibular functional tests and inner ear MRI in Meniere\u2019s disease.Ear and Hearing. Publish Ahead of Print APR 2018. DOI:10.1097\/AUD.0000000000000584.","DOI":"10.1097\/AUD.0000000000000584"},{"key":"197395r18","unstructured":"Bailey C.M., Graham M.D., Lawrence M.: Recovery from prolonged sensorineuralhearing loss. Am. J. Otol, 1982; 4(1): 1\u20138."},{"key":"197395r19","doi-asserted-by":"crossref","unstructured":"Sakurai T., Yamane H., Nakai Y.: Some aspect of hearing change in Meniere\u2019spatients. Act Otolaryngol Suppl, 1991; 486: 92\u201398.","DOI":"10.3109\/00016489109134987"},{"key":"197395r20","unstructured":"Lopez-Escamez J.A., Carey J., Chung W.H., Goebel J.A., Magnusson M. etal.: Diagnostic criteria for Meni\u00e8re\u2019s disease. J Vestib Res., 2015; 25(1): 1\u20137."},{"key":"197395r21","unstructured":"Frejo L., Martin-Sanz E., Teggi R., Trinidad G., Soto-Varela A. et al.: Extendedphenotype and clinical subgroups in unilateral Meniere disease: A cross-sectionalstudy with cluster analysis. Clin Otolaryngol., 2017; 42(6): 1172\u20131180."},{"key":"197395r22","unstructured":"Frejo L., Soto-Varela A., Santos-P\u00e9rez S., Aran I., Batuecas-Caletrio A. et al.:Clinical Subgroups in Bilateral Meniere Disease. Front Neurol., 2016; 7: 182."},{"key":"197395r23","unstructured":"Lopez-Escamez J.A., Viciana D., Garrido-Fernandez P.: Impact of bilateralityand headache on health-related quality of life in Meniere\u2019s disease. Ann OtolRhinol Laryngol., 2009; 118(6): 409\u2013416."}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0013.7927","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0013.7927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T13:59:08Z","timestamp":1598018348000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0013.7927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,5]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,3,25]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0013.7927","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,5]]}}}